UBS AM’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-97,160
Closed -$17.5M 2650
2017
Q3
$17.5M Sell
97,160
-183,290
-65% -$33M 0.02% 760
2017
Q2
$29.1M Sell
280,450
-32,118
-10% -$3.33M 0.03% 599
2017
Q1
$24.5M Sell
312,568
-91,569
-23% -$7.19M 0.03% 648
2016
Q4
$18.1M Buy
404,137
+11,291
+3% +$506K 0.02% 717
2016
Q3
$21.9M Sell
392,846
-14,390
-4% -$804K 0.02% 649
2016
Q2
$20.4M Buy
407,236
+29,658
+8% +$1.48M 0.02% 672
2016
Q1
$17.3M Buy
377,578
+10,167
+3% +$467K 0.02% 708
2015
Q4
$22.6M Sell
367,411
-53,206
-13% -$3.28M 0.03% 626
2015
Q3
$23.4M Sell
420,617
-1,782
-0.4% -$99.2K 0.03% 633
2015
Q2
$25.8M Buy
422,399
+93,599
+28% +$5.71M 0.02% 632
2015
Q1
$19M Buy
328,800
+319,500
+3,435% +$18.4M 0.02% 723
2014
Q4
$536K Sell
9,300
-66,300
-88% -$3.82M ﹤0.01% 1911
2014
Q3
$2.16M Buy
+75,600
New +$2.16M ﹤0.01% 1279